Patients in low-income areas more sensitive to co-payment changes
The study investigated whether individuals in low-income areas are more strongly influenced by rising prescription drug co-payments than individuals in higher income areas.
The relationship between medication adherence and income level may contribute to the disparities in health observed across socioeconomic groups, according to a recent study published in the Journal of General Internal Medicine.
The study, funded by GlaxoSmithKline, investigated whether individuals who reside in low-income areas are more strongly influenced by rising prescription drug co-payments than individuals residing in higher income areas.
"Based on our analysis, it is likely that increased co-payments, intended to control costs, will exacerbate the disparities seen across socioeconomic groups," Michael Chernew, PhD, professor, Department of Health Care Policy, Harvard Medical School, said in a statement released by GlaxoSmithKline.
For the complete story, click here.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, clickhere.
Psychiatric Pharmacist Working to Optimize Treatment, Improve Patient Safety
December 13th 2024A conversation with Nina Vadiei, PharmD, BCPP, clinical associate professor in the Division of Pharmacotherapy at University of Texas at Austin College of Pharmacy and a clinical pharmacy specialist in psychiatry at the San Antonio State Hospital.
